- ALNAQ Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Allena Pharmaceuticals (ALNAQ) S-3Shelf registration
Filed: 3 Dec 18, 4:36pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement on FormS-3 and related Prospectus of Allena Pharmaceuticals, Inc. for the registration of $200,000,000 of common stock, preferred stock, debt securities, warrants and/or units and to the incorporation by reference therein of our report dated March 27, 2018, with respect to the consolidated financial statements of Allena Pharmaceuticals, Inc. included in its Annual Report (Form10-K) for the year ended December 31, 2017, filed with the Securities and Exchange Commission.
/s/ Ernst and Young LLP |
Boston, Massachusetts
December 3, 2018
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.